ASO Author Reflections: Upfront Surgery Followed by Adjuvant Therapy: An Option for IIIA-N2 Non-small Cell Lung Cancer

被引：0
|
作者：
Fu, Fangqiu [1 ,2 ,3 ,4 ]
Zhang, Yang [1 ,2 ,3 ,4 ]
Chen, Haiquan [1 ,2 ,3 ,4 ]
机构：
[1] Fudan Univ, Dept Thorac Surg, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, State Key Lab Genet Engn, Shanghai, Peoples R China
[3] Fudan Univ, Inst Thorac Oncol, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
来源：
ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / 13期
关键词：
D O I：
10.1245/s10434-023-14265-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：8284 / 8284
页数：1
相关论文
共 50 条
  • [1] ASO Author Reflections: Upfront Surgery Followed by Adjuvant Therapy: An Option for IIIA-N2 Non-small Cell Lung Cancer
    Fangqiu Fu
    Yang Zhang
    Haiquan Chen
    [J]. Annals of Surgical Oncology, 2023, 30 : 8284 - 8284
  • [2] Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery
    Shin, Sumin
    Kim, Hong Kwan
    Cho, Jong Ho
    Choi, Yong Soo
    Kim, Kwhanmien
    Kim, Jhingook
    Zo, Jae Ill
    Sun, Jong-Mu
    Ahn, Myung-Ju
    Park, Keunchil
    Pyo, Hongryull
    Ahn, Yong Chan
    Shim, Young Mog
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2602 - 2613
  • [3] Role of surgery for stage IIIA-N2 non-small cell lung cancer
    Yang, Fan
    Wang, Jun
    [J]. THORACIC CANCER, 2011, 2 (03) : 90 - 94
  • [4] Induction erlotinib therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong Wen-Zhao
    Yang Xue-Ning
    Guo Ai-Lin
    Chen Hua-Jun
    Su Jian
    Liao Ri-Qiang
    Zhou Qing
    Nie Qiang
    Xu Chong-Rui
    Yang Jin-Ji
    Wu Yi-Long
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S590 - S591
  • [5] Induction eriotinib therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong, W.
    Yang, X.
    Liao, R.
    Nie, Q.
    Zhang, X.
    Su, J.
    Zhou, Q.
    Xu, C.
    Yang, J.
    Wu, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Surgery for stage IIIA-N2 non-small cell lung cancer: the jury is still out!
    Berzenji, Lawek
    Beckers, Paul
    Van Schil, Paul E.
    [J]. JOURNAL OF THORACIC DISEASE, 2019, 11 : S1153 - S1156
  • [7] Recent Clinical Outcomes of Upfront Surgery Followed by Adjuvant Therapy for Resectable Pathological N2 Non-Small Cell Lung Cancer
    Yun, J. K.
    Chong, Y.
    Jeong, Y. H.
    Lee, H. P.
    Bok, J. S.
    Lee, G. D.
    Kim, H. R.
    Kim, Y.
    Kim, D. K.
    Park, S.
    Choi, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S410 - S411
  • [8] Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer
    Lee, Hyun Woo
    Noh, O. Kyu
    Oh, Young-Taek
    Choi, Jin-Hyuk
    Chun, Mison
    Kim, Hwan-Ik
    Heo, Jaesung
    Ahn, Mi Sun
    Park, Seong Yong
    Park, Rae Woong
    Yoon, Dukyong
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (03): : 621 - 627
  • [9] ASO Author Reflections: Survival Impact of N2 in Non-small Cell Lung Cancer
    Clement-Duchene, Christelle
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 944 - 945
  • [10] ASO Author Reflections: Survival Impact of N2 in Non-small Cell Lung Cancer
    Christelle Clément-Duchêne
    [J]. Annals of Surgical Oncology, 2018, 25 : 944 - 945
12345